Objective: In 2018, a survey was conducted with students on a Historically Black College and University (HBCU) campus that showed a significant lack of utilization of both on and off campus mental health resources. The primary outcome of this survey is to evaluate lack of utilization of mental health resources at an HBCU to effectively promote student mental wellness.
Methods: A short electronic survey was administered to students to assess underutilization.
Background: Although not formally highlighted as a risk factor in current practice guidelines, several observational studies have reported a possible association between antipsychotic use and development of venous thromboembolism (VTE). However, it is unclear to what extent the risk is elevated.
Case Report: Described are 2 cases of VTE following recent initiation of second-generation antipsychotics in elderly patients.
Psychopharmacol Bull
March 2018
Introduction: Long-acting injectable (LAI) antipsychotics were developed as a way to decrease pill burden and simplify medication regimens by allowing less frequent administration to assist with medication adherence.
Methods: The purpose of this study was to determine whether LAI antipsychotics prevent or delay hospital readmission in patients with a known history of medication non-adherence. The study is a retrospective evaluation of 240 men and women 18-65 years of age diagnosed with bipolar disorder, schizophrenia, or schizoaffective disorder discharged from an inpatient state hospital over a 2 year period of time on a LAI antipsychotic (fluphenazine LAI, haloperidol LAI, risperidone LAI or paliperidone LAI) or oral antipsychotic.